1. Bergan, T., Dalhoff, A., Thorsteinsson, S. E. A review of the pharmacokinetics and tissue penetration of ciprofloxacin. In:Findlay, R. (ed.): Ciprofloxacin. A new 4-quinolone. Sieber and McIntyre, Hong Kong 1985, pp. 23–36.
2. Bergan, T., Thorsteinsson, S. B., Kolstad, I. M., Johnsen, S. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses. Europ. J. Clin. Microbiol. 5 (1986) 187–192.
3. Borner, K., Höffken, G., Lode, H., Koeppe, P., Prinzing, C., Glatzel, P., Wiley, R., Olschweski, P., Sievers, B., Reinitz, D. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur. J. Clin. Microbiol. 5 (1986) 179–186.
4. Dudley, M. N., Ericson, J., Zinner, S. H.: Effect of dose on the pharmacokinetics of intravenous ciprofloxacin lactate in man. Twenty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis 1985, abstract no. 1004, 1985.
5. Matsumoto, F. A study of the pharmacokinetics of ciprofloxacin in humans and animals.Findlay, R. (ed.): Ciprofloxacin — A new 4-quinolone; Sieber and McIntyre, Hong Kong, 1985, pp. 37–42.